Showing results (461-470 of 495) with videos related to

Sort By:
Pageof 50
Nature Communications|September 1, 2021
Neural signatures of hyperdirect pathway activity in Parkinson's diseaseAshwini Oswal, Chunyan Cao, Chien-Hung Yeh, et al.
British Journal of Haematology|December 29, 2023
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based studyJoachim Baech, Simon Husby, Trine Trab, et al.
Blood Advances|June 9, 2022
Risk of diabetes and the impact on preexisting diabetes in patients with lymphoma treated with steroid-containing immunochemotherapyJoachim Baech, Marianne Tang Severinsen, Andreas K Øvlisen, et al.
Journal of Geriatric Oncology|November 17, 2023
Risk of dementia among older patients with lymphoma: A Danish nationwide matched cohort studyEva Futtrup Maksten, Lasse Hjort Jakobsen, Boris Modrau, et al.
The European Journal of Neuroscience|March 18, 2009
Gamma activity and reactivity in human thalamic local field potentialsFlorian Kempf, Christof Brücke, Farid Salih, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 16, 2018
Phase-Dependent Suppression of Beta Oscillations in Parkinson's Disease PatientsAbbey B Holt, Eszter Kormann, Alessandro Gulberti, et al.
Blood|August 19, 2017
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapyChristian W Eskelund, Christina Dahl, Jakob W Hansen, et al.
Blood Neoplasia|April 30, 2026
CD20 negativity at the start of second-line therapy predicts a shorter overall survival in B-cell lymphomasSanaz Mehdi Gholy, Torgerð Ranadóttir, Olafur Birgir Davidsson, et al.
Blood|December 25, 2009
The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT)Christian H Geisler, Arne Kolstad, Anna Laurell, et al.
Blood|December 21, 2021
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphomaLeo Meriranta, Amjad Alkodsi, Annika Pasanen, et al.
Pageof 50